deltatrials
Terminated PHASE1 INTERVENTIONAL 1-arm NCT01828294

Subcutaneous Ig Maintenance Therapy for Myasthenia Gravis (SIMM)

Sponsor: CSL Behring

Updated 9 times since 2017 Last updated: Apr 1, 2019 Started: Oct 31, 2011 Primary completion: Dec 31, 2017 Completion: Dec 31, 2017
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Study stopped by sponsor due to difficulty enrolling at site

A PHASE1 clinical study on Myasthenia Gravis, this trial is terminated or withdrawn. The trial is conducted by CSL Behring and has accumulated 9 data snapshots since 2011. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshotTerminated~Feb 2017 – ~Jan 2018 · 11 months · monthly snapshotTerminated~Jan 2018 – ~Jun 2018 · 5 months · monthly snapshotTerminated~Jun 2018 – ~May 2019 · 11 months · monthly snapshotTerminated~May 2019 – ~Jan 2021 · 20 months · monthly snapshotTerminated~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotTerminated~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotTerminated~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshotTerminated~Sep 2025 – present · 10 months · monthly snapshotTerminated

Change History

9 versions recorded
  1. Sep 2025 — Present [monthly]

    Terminated PHASE1

  2. Sep 2024 — Sep 2025 [monthly]

    Terminated PHASE1

  3. Jul 2024 — Sep 2024 [monthly]

    Terminated PHASE1

  4. Jan 2021 — Jul 2024 [monthly]

    Terminated PHASE1

  5. May 2019 — Jan 2021 [monthly]

    Terminated PHASE1

    Phase: NAPHASE1

Show 4 earlier versions
  1. Jun 2018 — May 2019 [monthly]

    Terminated NA

  2. Jan 2018 — Jun 2018 [monthly]

    Terminated NA

  3. Feb 2017 — Jan 2018 [monthly]

    Terminated NA

  4. Jan 2017 — Feb 2017 [monthly]

    Terminated NA

    First recorded

Oct 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • CSL Behring
  • St. Louis University
Data source: St. Louis University

For direct contact, visit the study record on ClinicalTrials.gov .